BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Metabolomics Society - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Metabolomics Society
X-ORIGINAL-URL:https://metabolomicssociety.org
X-WR-CALDESC:Events for Metabolomics Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20130101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=UTC:20140428T000000
DTEND;TZID=UTC:20140429T235959
DTSTAMP:20260430T025636
CREATED:20231115T195317Z
LAST-MODIFIED:20231115T195412Z
UID:5511-1398643200-1398815999@metabolomicssociety.org
SUMMARY:Companion Diagnostics: From Biomarker Identification to Market Entry
DESCRIPTION:The New York Academy of Sciences is proud to present: \nCompanion Diagnostics: From Biomarker Identification to Market Entry \nLocation: 7 World Trade Center. 250 Greenwich St\, 40th Fl. New York\, NY 10007 \nThe recent growth in complex biological data has enabled a major paradigm shift in healthcare away from “one-size-fits-all” approaches towards customized\, patient-tailored therapies. Biomarker-based companion diagnostics (CDx)\, designed to identify responsive patient sub-populations or those likely to experience adverse drug effects\, lie at the heart of this personalized\, precision medicine movement. \nThis 2-day conference will provide a neutral forum for international scientists and clinicians from academia\, industry\, and government — as well as healthcare policy makers\, regulatory experts\, insurance sector representatives\, and other stakeholders — to discuss research\, financial\, and regulatory strategies that will facilitate CDx development and integration into clinical care. Presentations will illustrate successes and failures based on case studies; evaluate emerging applications of technologies such as epigenetics\, bioinformatics\, and nanotechnology; analyze diverse therapeutic target areas including the pioneering field of cancer along with inflammatory\, infectious\, cardiovascular\, metabolic\, and neurodegenerative diseases; recognize regulatory hurdles; and formulate solutions to better improve public health with CDx and personalized medicine. \nFor more information see http://www.nyas.org/CDx2014
URL:https://metabolomicssociety.org/event/companion-diagnostics-from-biomarker-identification-to-market-entry/
LOCATION:The New York Academy of Sciences\, USA\, 7 World Trade Center\, 250 Greenwich St\, 40th Fl\, New York\, NY\, 10007\, United States
END:VEVENT
END:VCALENDAR